Overall, we observed that primary DLBCL patient samples (DFBL-18689 and DLBL-86381), DLBCL cell lines (TMD8 and OCI-Ly1-R) and certain primary CLL patient sample (CLL PT.3) have relatively reduced BCL-2 dependence. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.